Zhuzhou Qianjin Pharmaceutical Co.,Ltd.’s Net Profit Rose 6.9% in First Three Quarters of 2023

Zhuzhou Qianjin Pharmaceutical Co.,Ltd. (株洲千金药业股份有限公司) (600479.SH) reported a net profit of 239.6 million yuan in the first three quarters of 2023, up 6.9% year-on-year.

Meanwhile, the company posted 2.8 billion yuan in revenue, down 4% year-on-year.

At the end of the reporting period, it had 4.5 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 35.8%.